REVIEW
Published on 21 Sep 2026
Mitochondrial dysfunction as a metabolic checkpoint of immunotherapy response in colorectal cancer
doi 10.3389/fimmu.2026.1908222
- 708 views
Articles
ORIGINAL RESEARCH
Published on 09 Jun 2026
Site-specific neoepitope induction by RNA editing reprograms tumor immunogenicity
doi 10.3389/fimmu.2026.1839930
- 1,131 views
REVIEW
Published on 03 Jun 2026
The relationship between gut microbiota and cancer immune response and immunotherapy
doi 10.3389/fimmu.2026.1833138
- 1,743 views
- 2 citations
ORIGINAL RESEARCH
Published on 03 Jun 2026
Stratified lymph node yield thresholds after neoadjuvant immunochemotherapy: a surgical benchmark for survival in oral squamous cell carcinoma
doi 10.3389/fimmu.2026.1782877
- 1,599 views
CASE REPORT
Published on 02 Jun 2026
Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer – a case report and review of the literature
doi 10.3389/fonc.2026.1780838
- 1,138 views
CASE REPORT
Published on 29 May 2026
Case Report: Converting an immunologically “cold” tumor: exceptional response to cadonilimab plus chemotherapy in microsatellite-stable pancreatic cystadenocarcinoma
doi 10.3389/fimmu.2026.1735785
- 1,569 views
REVIEW
Published on 21 May 2026
Antibody-drug conjugates in recurrent or metastatic HNSCC: relevant targets, clinical development, and future prospects
doi 10.3389/fimmu.2026.1828131
- 3,931 views
- 1 citation
REVIEW
Published on 14 May 2026
Adoptive cell therapies in solid tumors: current clinical landscape, challenges, and future directions
doi 10.3389/fimmu.2026.1800292
- 4,022 views
- 5 citations
CASE REPORT
Published on 12 May 2026
Ivonescimab monotherapy in an elderly patient with EGFR-TKI-resistant advanced lung adenocarcinoma and pericardial effusion: a case report and literature review
doi 10.3389/fimmu.2026.1728444
- 1,614 views
BRIEF RESEARCH REPORT
Published on 11 May 2026
Pembrolizumab for MSI-high/TMB-high bone and soft tissue sarcomas: a retrospective single-institution study
doi 10.3389/fonc.2026.1751879
- 1,467 views
CASE REPORT
Published on 23 Apr 2026
Multiple autologous tumor-infiltrating lymphocyte (LM103 infusion) therapy combined with immune checkpoint inhibitor induces repeated tumor regression in a patient with aggressive mucosal melanoma: a case report and literature review
doi 10.3389/fonc.2026.1789442
- 1,657 views
REVIEW
Published on 21 Apr 2026
Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms
doi 10.3389/fimmu.2026.1772428
- 4,113 views
